Home
/
News updates
/
Regulatory changes
/

Sec to reveal decision on hbar etf โ€“ community reacts

SEC Review of Canary HBAR ETF | Investors Await SEC Decision

By

Sophie Chang

Jul 7, 2025, 08:38 PM

3 minutes reading time

A graphic showing the SEC building with financial charts and HBAR logo, highlighting the ETF decision.
popular

Investors are closely watching the Canary HBAR ETF, currently under review by the SEC until July 7, 2025. Approval could simplify large fund investments in HBAR, but sentiments among community members show divided opinions on the significance of this decision.

Current Status of the ETF Review

The ETFโ€™s application remains at a crucial point, but it's essential to understand that today marks only a deadline for written comments. Sources indicate the SEC might not make a definitive decision until September 9, 2025. An individual commented, "The SEC decision isnโ€™t for a couple months," which reflects the sentiments within the community hoping for clarity on this matter.

Community Reactions: What Are People Saying?

Comments from various forums reveal three main themes:

  1. Skepticism About ETF Impact: Many individuals believe the ETF approval wonโ€™t significantly change the HBAR landscape. One commenter noted, "The future does not rely on some orgโ€™s ETF application. Moving the needle on TPS and network revenue is whatโ€™s important."

  2. Confusion Over Timelines: While today is the last day for public comment, a user highlighted the confusion surrounding the actual timeline for the SEC's actions, stating, "The next critical deadline for SEC action is more likely September, not today."

  3. Optimism for HBAR's Potential: Some argue that a successful ETF would lead other advancements in the HBAR network, with one expressing hope that "one has to move first, and I suspect it will be an ETF sometime soon."

"Public comment submission ends today. Rebuttal commentary is due July 21," a participant reminded, emphasizing the ongoing process.

Key Insights to Consider

  • โ–ฝ Comments reflect mixed feelings, with skepticism outweighing enthusiasm.

  • ๐Ÿ” "Each one will follow the other," noted a commenter, underlining the interconnectedness of potential ETF approval and HBAR's performance.

  • ๐Ÿ“… The SEC continues to collect input prior to its longer-term decision process.

The End

The Canary HBAR ETF's fate is still uncertain as the SEC deliberates. While many in the community remain skeptical about the ETF's impact on HBAR's growth, the upcoming deadlines for public comments and rebuttals suggest that discussion will continue to shape perceptions around this investment vehicle.

Stay tuned for more updates as events unfold!

Navigating the Road Ahead for HBAR ETF

As the SEC inches closer to its decision on the Canary HBAR ETF, thereโ€™s a solid chance we could see approval by September. Many believe that if the ETF gets the green light, it could lead to a significant influx of institutional investments, boosting confidence in HBAR's market position. Conversely, skepticism remains prevalent among the community, with some experts estimating about a 40% chance that the ETF could actually drive substantive change in the ecosystem. How the SEC's decision plays out will likely pivot on feedback gathered during this public comment period, with reactions shaping future developments.

Crossing the Streams of History

This scenario can be likened to the initial public offering rush around tech companies in the late 1990s. Just as those market milestones sparked both excitement and doubt among investors, todayโ€™s situation reflects that balancing act between optimism and caution. Approval of an ETF might be the first domino to fall, mirroring how early tech stocks set off a wave of innovationโ€”driving not just their own growth but also altering the landscape for other players in the market. Just as investors at that time watched closely for signs of validation, the HBAR community now awaits the SECโ€™s forthcoming decisions, with the future tightly interwoven in the hands of a few regulatory choices.